Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

The Index › Metabolic medicine › Whose sales may the drugs shrink?

Darden

DRI

Darden owns and operates full-service restaurant chains such as Olive Garden and LongHorn Steakhouse, whose sales depend on consumers choosing to dine out. We follow it because its sales depend on eating and drinking habits that weight-loss drugs and health trends may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
DRI
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$226.35
close of 6 Nov 2026 · Massive and Yahoo agree
The day's range$223.32 – $230.31
6 Nov 2026 · both providers agree
52-week range$169.00 – $233.98
intraday low 20 Nov 2025 · intraday high 5 Nov 2026 · 251 sessions to 6 Nov 2026 · both providers agree
Market value$25.6 billion
the 6 Nov 2026 close × 113,143,224 shares outstanding on the 10-Q cover, as of 21 Sep 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

23 Oct 20268-K · period ending 22 Oct 2026
2 Oct 202610-Q · period ending 30 Aug 2026
24 Sep 20268-K · period ending 23 Sep 2026
24 Sep 20268-K · period ending 24 Sep 2026
24 Jul 202610-K · period ending 31 May 2026
25 Jun 20268-K · period ending 24 Jun 2026
27 Mar 202610-Q · period ending 22 Feb 2026
19 Mar 20268-K · period ending 19 Mar 2026
30 Dec 202510-Q · period ending 23 Nov 2025
18 Dec 20258-K · period ending 18 Dec 2025
26 Sep 202510-Q · period ending 24 Aug 2025
19 Sep 20258-K · period ending 17 Sep 2025
18 Sep 20258-K · period ending 18 Sep 2025
18 Jul 202510-K · period ending 25 May 2025
20 Jun 20258-K · period ending 13 Jun 2025
1 Apr 202510-Q · period ending 23 Feb 2025
20 Mar 20258-K · period ending 20 Mar 2025
28 Jan 20258-K · period ending 27 Jan 2025
2 Jan 202510-Q · period ending 24 Nov 2024
19 Dec 20248-K · period ending 19 Dec 2024
9 Dec 20248-K · period ending 9 Dec 2024

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-10-02 · period ending 2026-08-30

Read the filing

Machine-readable

/index/DRI.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Whose sales may the drugs shrink?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-10-02 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Darden. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-10-02
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)